-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ov4M4lZJdwZuNmoL7lsGrwnm2mb6uV1Vb/pMX0vXkXB1msH9i+EMbLDKWsSnemvv YMfuAPyh99yoO76oqBqD6w== 0001104659-04-021150.txt : 20040728 0001104659-04-021150.hdr.sgml : 20040728 20040728082521 ACCESSION NUMBER: 0001104659-04-021150 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040728 ITEM INFORMATION: FILED AS OF DATE: 20040728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PLC SYSTEMS INC CENTRAL INDEX KEY: 0000879682 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 043153858 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11388 FILM NUMBER: 04934538 BUSINESS ADDRESS: STREET 1: 10 FORGE PK CITY: FRANKLIN STATE: MA ZIP: 02038 BUSINESS PHONE: 5085418800 MAIL ADDRESS: STREET 1: 10 FORGE PARK CITY: FRANKLIN STATE: MA ZIP: 02038 8-K 1 a04-8374_18k.htm 8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):  July 28, 2004

 

PLC Systems Inc.

(Exact name of registrant as specified in charter)

 

Yukon Territory, Canada

 

1-11388

 

04-3153858

(State or other juris-
diction of incorporation

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

 

 

 

 

10 Forge Park, Franklin, Massachusetts

 

02038

(Address of principal executive offices)

 

(Zip Code)

 

 

 

Registrant’s telephone number, including area code: (508) 541-8800

 

 

 

Not applicable

(Former name or former address, if changed since last report)

 

 



 

Item 12.  Results of Operations and Financial Condition

 

On July 28, 2004, PLC Systems Inc. announced its financial results for the quarter ended June 30, 2004.  The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date: July 28, 2004

PLC SYSTEMS INC.

 

 

 

By:

 

 

 

James G. Thomasch, Senior Vice
President, Finance and Administration
and Chief Financial Officer

 

3



 

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press Release dated July 28, 2004

 

4


EX-99.1 2 a04-8374_1ex99d1.htm EX-99.1

Exhibit 99.1

 

Contact: John Jordan

Director of Investor Relations

508-541-8800, ext. 145

 

PLC SYSTEMS REPORTS SECOND QUARTER RESULTS

 

Company On Track To Meet Optimaze Research and Development Project Milestones —

 

Franklin, MA, July 28, 2004 – PLC Systems Inc. (AMEX: PLC), a worldwide leader in cardiac laser technologies, today reported financial results for the three and six months ended June 30, 2004.

 

Second quarter total revenues were $1,796,000 compared with $2,011,000 in the second quarter of 2003.  The net loss for the second quarter of 2004 was $251,000, or $.01 per share, compared to net income of $203,000, or $.01 per share, in the second quarter of 2003.

 

Total revenues for the six months ended June 30, 2004 were $3,705,000 compared to total revenues of $3,745,000 for the six months ended June 30, 2003.  The net loss for the six months ended June 30, 2004 was $601,000, or $.02 per share, compared to net income of $218,000, or $.01 per share, for the six months ended June 30, 2003.

 

“We made significant progress in executing our plan to grow PLC beyond its single product focus during the past two quarters,” stated Mark R. Tauscher, president and chief executive officer of PLC Systems.  “As we entered this year, PLC was a single product medical device company.  As a result of our efforts, we believe that PLC is on target to enter next year as a company with an expanded product portfolio and a bright future.”

 

Tauscher continued, “During the quarter, the TMR business continued at a reasonable pace and we made positive advancements in our new business initiatives.  The Optimaze project is on schedule and we believe that it will generate revenue for PLC in the first quarter of 2005.”

 

During the second quarter of 2004,  11 next-generation CO2 Heart Lasers (HL2) were delivered to United States hospitals through Edwards Lifesciences Corporation (NYSE: EW), PLC’s exclusive U.S. sales and marketing partner.  Six of the 11 HL2 shipments were new lasers and five were redeployed lasers.

 

PLC ended the second quarter of 2004 with 168 CO2 Heart Lasers located at heart centers throughout the U.S., comprised of 120 HL2 customers and 48 HL1 customers.  As of June 30, 2004, PLC’s U.S. laser base (HL1 and HL2) had increased by 17 percent during the preceding twelve months.  More significantly, PLC’s U.S. HL2 installed base grew to 120 lasers as of June 30, 2004, up 35 percent from June 30, 2003.

 

- more -

 



 

During the second quarter of 2004, Edwards delivered 502 disposable kits to United States hospitals.  In the second quarter of 2003, a total of 524 disposable kits were shipped to United States hospitals.  A total of 382 disposable kits were delivered domestically during the first quarter of 2004.

 

Tauscher concluded, “As we drive toward generating revenue in 2005 from the Optimaze project, our key objectives are as follows: infrastructure build out completed in the third quarter; infrastructure validation completed in the fourth quarter; Optimaze laser product release in the fourth quarter; and Optimaze disposable hand piece product release in the first quarter of 2005.”

 

In conjunction with announcing second quarter results, PLC Systems will be hosting a conference call today, July 28, at 11:00 a.m. Eastern Time.  The call may be joined via telephone by dialing (800) 259-0251 at least five minutes prior to the start of the call.  The passcode is: 90535033.  A live Webcast of the call will be available and accessible at the investor relations section of the Company’s website at www.plcmed.com.  A recording of the conference call will be available for the next month on PLC’s website.

 

This press release contains “forward-looking” statements. For this purpose, any statements contained in this press release that relate to prospective events or developments are deemed to be forward-looking statements. Words such as “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions are intended to identify forward-looking statements. Our statements of our objectives are also forward looking statements. While we may elect to update forward-looking statements in the future, we specifically disclaim any obligation to do so, even if our estimates change, and you should not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release.  Actual results could differ materially from those indicated by such forward-looking statements as a result of a variety of important factors, including we may be unable to successfully develop products under our new agreement with Edwards and Edwards may be unsuccessful in distributing these products, operational changes, competitive developments may affect the market for our products, regulatory approval requirements may affect the market for our products, we may be unable to convince health care professionals and third party payers of the medical and economic benefits of the CO2 Heart Lasers and the Optimaze System, and there can be no assurance that all payers will reimburse health care providers who perform TMR procedures or that reimbursement, if provided, will be adequate, and additional risk factors described in our Report on Form 10-K for the year ended December 31, 2003, and our other SEC reports.

 

PLC Systems, PLC Medical Systems, PLC and CO2 Heart Laser are trademarks of PLC Systems Inc. Edwards Lifesciences, Edwards and Optimaze are trademarks of Edwards Lifesciences Corporation.

 

2



 

PLC SYSTEMS INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

Revenues:

 

 

 

 

 

 

 

 

 

Product sales

 

$

1,354

 

$

1,578

 

$

2,885

 

$

2,984

 

Placement and service fees

 

442

 

433

 

820

 

761

 

Total revenues

 

1,796

 

2,011

 

3,705

 

3,745

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues:

 

 

 

 

 

 

 

 

 

Product sales

 

575

 

499

 

1,165

 

1,024

 

Placement and service fees

 

172

 

125

 

348

 

241

 

Total cost of revenues

 

747

 

624

 

1,513

 

1,265

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

1,049

 

1,387

 

2,192

 

2,480

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

866

 

975

 

1,856

 

1,831

 

Research and development

 

516

 

220

 

1,045

 

461

 

Total operating expenses

 

1,382

 

1,195

 

2,901

 

2,292

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

(333

)

192

 

(709

)

188

 

 

 

 

 

 

 

 

 

 

 

Other income, net

 

82

 

11

 

108

 

30

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(251

)

$

203

 

$

(601

)

$

218

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted earnings (loss) per share

 

$

(0.01

)

$

0.01

 

$

(0.02

)

$

0.01

 

 

 

 

 

 

 

 

 

 

 

Average shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

30,056

 

29,810

 

29,990

 

29,804

 

Diluted

 

30,056

 

30,019

 

29,990

 

29,916

 

 

 

 

 

 

 

 

 

 

 

CONDENSED BALANCE SHEET

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30,
2004

 

December 31,
2003

 

Cash and cash equivalents

 

 

 

 

 

$

10,251

 

$

6,377

 

Total current assets

 

 

 

 

 

13,399

 

9,367

 

Total assets

 

 

 

 

 

13,914

 

9,849

 

Total current liabilities

 

 

 

 

 

2,429

 

1,962

 

Shareholders’ equity

 

 

 

 

 

7,038

 

7,556

 

 

# # #

 

3


-----END PRIVACY-ENHANCED MESSAGE-----